Oxford Science Enterprises portfolio company MiroBio to be acquired by Gilead Sciences for approximately $405 million

OXFORD, England, Aug. 4, 2022 /PRNewswire/ — Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses via its unique partnership with the University of Oxford, is pleased to announce its life sciences portfolio…

About the Author

has written 39694 stories on this site.

Copyright © 2010 Business and Corporate News.